Drug intelligence / Profile preview

Gaviscon Double Action

Development stage
Phase 3
Lead developer
Reckitt
Modality
Small Molecules
Administration
Oral
01

Overview

**Gaviscon Double Action** is an over-the-counter antacid and alginate combination product available as chewable tablets or oral suspension, primarily used for symptomatic relief of gastro-oesophageal reflux disease (GORD), heartburn, acid regurgitation, indigestion, and hyperacidity, including during pregnancy or postprandially. Upon ingestion, sodium alginate reacts with gastric acid to form a floating raft of alginic acid gel with near-neutral pH that impedes reflux by physically floating on stomach contents; calcium carbonate and sodium bicarbonate provide rapid acid neutralization (total capacity ~10 mEqH+ per lowest dose). Its physical mode of action avoids systemic absorption, with formulations that are sugar-free, lactose-free, aluminum-free, and gluten-free.[1][2][5]

Brand names
Gaviscon Double Action
Other names
Gaviscon Double Action MintGaviscon Dual ActionGaviscon Duo

Beyond the preview

Go deeper on Gaviscon Double Action.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gaviscon Double Action.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call